| scholarly article | Q13442814 |
| P2093 | author name string | Eugen Brailoiu | |
| Servio H Ramirez | |||
| G Cristina Brailoiu | |||
| Mary E Abood | |||
| Christine L Barlow | |||
| P2860 | cites work | Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA | Q24311854 |
| Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor | Q24679152 | ||
| A new generation of Ca2+ indicators with greatly improved fluorescence properties | Q27860793 | ||
| Platelet‐activating factor receptor and signal transduction mechanisms 1 | Q28209244 | ||
| The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors | Q28552564 | ||
| Platelet activating factor induces blood brain barrier permeability alteration in vitro | Q28579478 | ||
| The vascular distribution of the platelet-activating factor receptor | Q28581585 | ||
| Structure and function of the blood-brain barrier | Q29615699 | ||
| The blood-brain barrier/neurovascular unit in health and disease | Q29616335 | ||
| Impedance analysis of GPCR-mediated changes in endothelial barrier function: overview and fundamental considerations for stable and reproducible measurements | Q30373402 | ||
| Platelet-activating factor and related lipid mediators | Q33916020 | ||
| Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells | Q33962516 | ||
| Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. | Q34001078 | ||
| Membrane potential depolarization decreases the stiffness of vascular endothelial cells | Q34184038 | ||
| Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor | Q68401166 | ||
| Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation | Q68717619 | ||
| Platelet activating factor and leukotriene B4 induce hyperpolarization of human endothelial cells but depolarization of neutrophils | Q69829956 | ||
| Biochemical events associated with the stimulation of rabbit neutrophils by platelet-activating factor | Q70151510 | ||
| Stimulation of platelet-activating factor (PAF) receptors increases inositol phosphate production and cytosolic free Ca2+ concentrations in N1E-115 neuroblastoma cells | Q70787092 | ||
| Production of platelet-activating factor by porcine brain microvascular endothelial cells in culture | Q71014941 | ||
| Mechanism of the contractile response to platelet-activating factor (PAF) of the rat stomach fundus. II. PAF-induced phosphatidylinositol turnover and desensitization | Q72252887 | ||
| Correlations between PAF-acether and tumor necrosis factor in rheumatoid arthritis. Influence of parenteral corticosteroids | Q72304729 | ||
| Platelet-activating factor induced calcium mobilization and phosphoinositide metabolism in cultured bovine cerebral microvascular endothelial cells | Q72858700 | ||
| Influence of inhibitors on increase in intracellular free calcium and proliferation induced by platelet-activating factor in bovine oviductal cells | Q73038162 | ||
| Setting-up an in vitro model of rat blood-brain barrier (BBB): a focus on BBB impermeability and receptor-mediated transport | Q34400993 | ||
| Platelet activating factor-induced ceramide micro-domains drive endothelial NOS activation and contribute to barrier dysfunction | Q35006019 | ||
| Platelet activating factor contributes to vascular leak in acute dengue infection | Q35043739 | ||
| Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide | Q35310056 | ||
| G protein-coupled estrogen receptor-mediated effects on cytosolic calcium and nanomechanics in brain microvascular endothelial cells. | Q36036783 | ||
| Tight junctions: molecular architecture and function | Q36400271 | ||
| Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin | Q36623039 | ||
| An in vivo assay to test blood vessel permeability | Q36804454 | ||
| Effect of ATP and platelet-activating factor on intracellular calcium concentrations of cultured oviductal cells from cows | Q36837157 | ||
| Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules | Q36995182 | ||
| The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants | Q37581875 | ||
| Endothelial calcium dynamics, connexin channels and blood-brain barrier function. | Q38121371 | ||
| Platelet-activating factor attenuation of long-term potentiation in rat hippocampal slices via protein tyrosine kinase signaling | Q38512226 | ||
| Mechanisms of modulation of brain microvascular endothelial cells function by thrombin | Q38725187 | ||
| Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases. | Q38950607 | ||
| Barrier function in the peripheral and central nervous system-a review. | Q39037187 | ||
| Calcium Signaling Is Dispensable for Receptor Regulation of Endothelial Barrier Function | Q39192621 | ||
| PAF activation of a voltage-gated R-type Ca2+ channel in human and canine aortic endothelial cells | Q39404173 | ||
| Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton | Q40027044 | ||
| Reliable in vitro measurement of nitric oxide released from endothelial cells using low concentrations of the fluorescent probe 4,5-diaminofluorescein | Q40776216 | ||
| Platelet-activating factor: a case for its role in CNS function and brain injury | Q41201167 | ||
| Platelet-activating factor in the CNS. | Q41335954 | ||
| Calcium-dependent and calcium-independent activation of the endothelial NO synthase | Q41534240 | ||
| Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung | Q41699178 | ||
| Radioligand binding of antagonists of platelet-activating factor to intact human platelets | Q42213272 | ||
| Platelet-activating factor synthesis by neutrophils, monocytes, and endothelial cells is modulated by nitric oxide production. | Q42439588 | ||
| Stimulus-response coupling in human platelets. Changes evoked by platelet-activating factor in cytoplasmic free calcium monitored with the fluorescent calcium indicator quin2. | Q42456897 | ||
| Production and effects of platelet-activating factor in the rat brain | Q42514420 | ||
| Cocaine inhibits store-operated Ca2+ entry in brain microvascular endothelial cells: critical role for sigma-1 receptors | Q43129017 | ||
| Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture | Q43651206 | ||
| Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis | Q44520927 | ||
| Platelet activating factor induces transient blood-brain barrier opening to facilitate edaravone penetration into the brain | Q44610359 | ||
| Hypoxia/aglycemia alters expression of occludin and actin in brain endothelial cells | Q45225666 | ||
| Platelet activating factor receptor (PAF-R) is found in a large endosomal compartment in human umbilical vein endothelial cells | Q46308082 | ||
| Platelet-activating factor receptor is essential for the development of experimental cerebral malaria | Q47994827 | ||
| Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence | Q48093176 | ||
| Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis. | Q48181308 | ||
| The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells | Q48300181 | ||
| Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats | Q48314697 | ||
| Platelet-activating factor (PAF) receptor in rat brain: PAF mobilizes intracellular Ca2+ in hippocampal neurons | Q48453173 | ||
| Blood-brain barrier breakdown by PAF and protection by XQ-1H due to antagonism of PAF effects | Q48553766 | ||
| Platelet-activating factor may stimulate both receptor-dependent and receptor-independent increases in [Ca2+] in human airway epithelial cells. | Q51640611 | ||
| Comparative measurements of membrane potentials with microelectrodes and voltage-sensitive dyes. | Q52694352 | ||
| Platelet-activating factor receptor (PAFR) plays a crucial role in experimental global cerebral ischemia and reperfusion. | Q53130784 | ||
| Mechanism of the contractile response to platelet-activating factor (PAF) of the rat stomach fundus. I. PAF-induced contractile response and calcium mobilization. | Q54040968 | ||
| Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. | Q55067651 | ||
| Stimulation of non-selective cation channels providing Ca2+ influx into platelets by platelet-activating factor and other aggregation inducers | Q67690672 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 105-113 | |
| P577 | publication date | 2018-03-06 | |
| P1433 | published in | Neuroscience | Q15708571 |
| P1476 | title | Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells. | |
| P478 | volume | 377 |
| Q91807444 | Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives |
| Q58801775 | Hydroxysafflor Yellow A Suppresses Platelet Activating Factor-Induced Activation of Human Small Airway Epithelial Cells |
| Q55446683 | Inflammation, not Cholesterol, Is a Cause of Chronic Disease. |
Search more.